Nahdi Medical Company

TADAWUL:4164.SR

128.4 (SAR) • At close July 1, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) SAR.

20242023202220212020201920182017
Revenue 9,446.428,713.6768,616.1888,066.2158,642.2077,824.6747,350.0037,056.423
Cost of Revenue 5,913.5545,277.9535,095.2964,761.5345,762.3815,856.2875,419.1825,048.866
Gross Profit 3,532.8663,435.7233,520.8923,304.6812,879.8261,968.3871,930.8212,007.558
Gross Profit Ratio 0.3740.3940.4090.410.3330.2520.2630.285
Reseach & Development Expenses 00000000
General & Administrative Expenses 57.93575.64868.82552.236310.64310.2260.731243.14
Selling & Marketing Expenses 393.027394.63352.601335.6481,958.6391,341.341929.09894.299
SG&A 450.9621,978.857421.426387.8841,794.4111,167.1011,264.5431,250.764
Other Expenses 2,208.71495.9114.45810.027-126.14211.5311.2151.777
Operating Expenses 2,659.6722,474.7682,534.9542,430.511,920.5531,155.571,263.3281,248.987
Operating Income 873.194960.9551,002.577919.569959.273812.816667.493758.571
Operating Income Ratio 0.0920.110.1160.1140.1110.1040.0910.108
Total Other Income Expenses Net -38.651-16.709-64.652-62.302-64.252-44.986-6.804-10.955
Income Before Tax 834.544944.246937.925857.267894.446768.632638.797751.948
Income Before Tax Ratio 0.0880.1080.1090.1060.1030.0980.0870.107
Income Tax Expense 13.8251.62850.11444.73845.3376.6328.14430.711
Net Income 820.724892.618887.812812.529849.116692.002610.653721.237
Net Income Ratio 0.0870.1020.1030.1010.0980.0880.0830.102
EPS 6.316.876.836.256.535.324.75.55
EPS Diluted 6.316.876.836.256.535.324.75.55
EBITDA 1,611.7021,643.6491,613.9431,506.7851,470.0721,319.313788.643899.532
EBITDA Ratio 0.1710.1890.1870.1870.170.1690.1070.127